X-71107770-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
This summary comes from the ClinGen Evidence Repository: NM_000206.3(IL2RG):c.1076C>T is a missense variant predicted to cause substitution of Alanine by Valine at amino acid 359 (p.Ala359Val). The highest population minor allele frequency in gnomAD v4 is 0.0001453 (126/867358) in European Non-Finnish population (PM2_Supporting, BS1, and BA1 are not met). To our knowledge, this variant has not been reported in the literature in individuals affected with IL2RG related conditions or in functional studies. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for X-linked severe combined immunodeficiency due to IL2RG deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: None (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA331121466/MONDO:0010315/129
Frequency
Consequence
ENST00000374202.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL2RG | NM_000206.3 | c.1076C>T | p.Ala359Val | missense_variant | 8/8 | ENST00000374202.7 | NP_000197.1 | |
IL2RG | XM_047442089.1 | c.*196C>T | 3_prime_UTR_variant | 7/7 | XP_047298045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL2RG | ENST00000374202.7 | c.1076C>T | p.Ala359Val | missense_variant | 8/8 | 1 | NM_000206.3 | ENSP00000363318 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112264Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34420
GnomAD3 exomes AF: 0.0000223 AC: 3AN: 134575Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42653
GnomAD4 exome AF: 0.000122 AC: 127AN: 1039816Hom.: 0 Cov.: 29 AF XY: 0.000129 AC XY: 43AN XY: 332752
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112264Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34420
ClinVar
Submissions by phenotype
X-linked severe combined immunodeficiency Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 15, 2020 | - - |
Uncertain significance, reviewed by expert panel | curation | ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen | Jan 10, 2024 | NM_000206.3(IL2RG):c.1076C>T is a missense variant predicted to cause substitution of Alanine by Valine at amino acid 359 (p.Ala359Val). The highest population minor allele frequency in gnomAD v4 is 0.0001453 (126/867358) in European Non-Finnish population (PM2_Supporting, BS1, and BA1 are not met). To our knowledge, this variant has not been reported in the literature in individuals affected with IL2RG related conditions or in functional studies. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for X-linked severe combined immunodeficiency due to IL2RG deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: None (VCEP specifications version 1). - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.1076C>T (p.A359V) alteration is located in exon 8 (coding exon 8) of the IL2RG gene. This alteration results from a C to T substitution at nucleotide position 1076, causing the alanine (A) at amino acid position 359 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at